Cargando…
Cost Effectiveness of Universal Hepatitis B Virus Screening in Patients Beginning Chemotherapy for Sarcomas or GI Stromal Tumors
PURPOSE: The value of screening for hepatitis B virus (HBV) infection before chemotherapy for nonhematopoietic solid tumors remains unsettled. We evaluated the cost effectiveness of universal screening before systemic therapy for sarcomas, including GI stromal tumors (GISTs). PATIENTS AND METHODS: D...
Autores principales: | Tan, Glorijoy, Zhou, Ke, Tan, Chee Hian, Matchar, David B., Farid, Mohamad, Quek, Richard, Ngeow, Joanne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Clinical Oncology
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5497623/ https://www.ncbi.nlm.nih.gov/pubmed/28717701 http://dx.doi.org/10.1200/JGO.2015.001669 |
Ejemplares similares
-
Treatment of gastrointestinal tumor (GIST) of the rectum requiring abdominoperineal resection following neoadjuvant imatinib: a cost-effectiveness analysis
por: Farid, Mohamad, et al.
Publicado: (2020) -
GI Synovial Sarcomas
por: Sinniah, Rajeev Palar, et al.
Publicado: (2012) -
Germline Mutations in Cancer Predisposition Genes are Frequent in Sporadic Sarcomas
por: Chan, Sock Hoai, et al.
Publicado: (2017) -
Prostatic Stromal Sarcoma in an Adolescent: The Role of Chemotherapy
por: Cavaliere, Elena, et al.
Publicado: (2014) -
Endoscopic subserosal dissection for a GI stromal tumor
por: Chen, Chun-Min, et al.
Publicado: (2022)